Adlon Therapeutics L.P. Joins the Prescription Drug Safety Network

14

STAMFORD, Conn.–(BUSINESS WIRE)–Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., today announced it will join the Prescription Drug Safety Network (“the Network”) and will advance its commitment to education about the responsible use of prescription stimulants by extending EVERFI’s efforts to deliver the innovative, evidence-based prevention curriculum to high school students. As part of its commitment to the Network, Adlon will provide support for EVERFI to deploy its school-base http://www.businesswire.com/news/home/20190709005144/en/Adlon-Therapeutics-L.P.-Joins-Prescription-Drug-Safety/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==